The effect of ketamine isomers on both mice behavioral responses and c-Fos expression in the posterior cingulate and retrosplenial cortices

Brain Res. 2000 Feb 28;857(1-2):188-92. doi: 10.1016/s0006-8993(99)02426-9.

Abstract

Ketamine, a non-competitive NMDA receptor antagonist, is a racemic mixture. S(+) ketamine is presumed to be more potent as an anesthetic than R(-) ketamine, and causes less postanesthetic stimulation of locomotor activity than R(-) ketamine in animals at equihypnotic doses. In the present study, we investigated the effect of S(+), R(-), and racemic ketamines on mice behavioral responses and c-Fos expression in the posterior cingulate and retrosplenial cortices (PC/RS), which are suggested to be the brain regions responsible for NMDA-receptor-antagonist-induced psychotomimetic activity. Ataxia and head weaving and c-Fos expression in the PC/RS were significantly more induced by both S(+) and racemic ketamines than by R(-) ketamine at the same dose. S(+) ketamine induced significantly more potent ataxia than racemic ketamine at the same dose. Ketamine-induced c-Fos expression in the PC/RS correlated well with the intensity of behavioral responses. These results imply that R(-) ketamine is weaker than both S(+) and racemic ketamines in a psychotomimetic effect. Also, S(+) ketamine is more potent than racemic ketamine in a psychotomimetic effect and possibly in an anesthetic effect. They also indicate that PC/RS is at least one of the specific brain regions responsible for ketamine-induced behavioral responses in animals and a psychotomimetic activity in humans.

MeSH terms

  • Animals
  • Behavior, Animal / drug effects*
  • Behavior, Animal / physiology*
  • Disease Models, Animal
  • Excitatory Amino Acid Antagonists / pharmacology*
  • Female
  • Gyrus Cinguli / cytology
  • Gyrus Cinguli / drug effects*
  • Gyrus Cinguli / metabolism*
  • Isomerism
  • Ketamine / pharmacology*
  • Mice
  • Mice, Inbred ICR
  • Proto-Oncogene Proteins c-fos / drug effects*
  • Proto-Oncogene Proteins c-fos / metabolism*
  • Schizophrenia / chemically induced
  • Schizophrenia / physiopathology

Substances

  • Excitatory Amino Acid Antagonists
  • Proto-Oncogene Proteins c-fos
  • Ketamine